Lingjun Zeng
Impact in
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems
- Advancements in Transdermal Drug Delivery
-
- Nanoparticle-Based Drug Delivery
Papers in
-
- Nanoplatforms for cancer theranostics 14
- Advanced Sensor and Energy Harvesting Materials 4
- Co-authors
- Guanghui Gao (3 shared papers)Bo Liu (2 shared papers)Zhenzhen Chen (9 shared papers)Chun Tao (5 shared papers)Zhihong Liu (11 shared papers)Zhihong Liu (5 shared papers)Minxin Zhang (6 shared papers)Xiaomu Hu (12 shared papers)
- Journals
- International Journal of Pharmaceutics (6 papers)ACS Applied Materials & Interfaces (6 papers)Biomedicine & Pharmacotherapy (2 papers)Journal of Pharmaceutical Sciences (1 paper)Drug Delivery and Translational Research (1 paper)
- Partner nations
- China
In The Last Decade
Lingjun Zeng
29 papers receiving 381 citations
Peers
Comparison fields: 5 of 81
- Pharmaceutical Science 68
- Biomaterials 70
- Biomedical Engineering 187
- Molecular Medicine 17
- Polymers and Plastics 43
Countries citing papers authored by Lingjun Zeng
This map shows the geographic impact of Lingjun Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingjun Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingjun Zeng more than expected).
Fields of papers citing papers by Lingjun Zeng
This network shows the impact of papers produced by Lingjun Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingjun Zeng. The network helps show where Lingjun Zeng may publish in the future.
Co-authors
The 25 scholars most cited alongside Lingjun Zeng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 47 | |
| 2 | 2020 | 44 | |
| 3 | 2023 | 39 | |
| 4 | 2023 | 27 | |
| 5 | 2023 | 26 | |
| 6 | 2012 | 26 | |
| 7 | 2020 | 22 | |
| 8 | 2023 | 22 | |
| 9 | 2023 | 16 | |
| 10 | 2021 | 15 | |
| 11 | 2016 | 13 | |
| 12 | 2020 | 11 | |
| 13 | 2022 | 11 | |
| 14 | 2015 | 10 | |
| 15 | 2023 | 10 | |
| 16 | 2024 | 9 | |
| 17 | 2023 | 8 | |
| 18 | 2025 | 4 | |
| 19 | 2022 | 4 | |
| 20 | 2024 | 4 |
About Lingjun Zeng
Lingjun Zeng is a scholar working on Biomedical Engineering, Molecular Biology, Pulmonary and Respiratory Medicine, Biomaterials and Immunology, having authored 37 papers that have together received 385 indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (14 papers), Nanoparticle-Based Drug Delivery (5 papers), Photodynamic Therapy Research Studies (5 papers), Immunotherapy and Immune Responses (5 papers), Advanced Sensor and Energy Harvesting Materials (4 papers), Conducting polymers and applications (3 papers), Advanced Nanomaterials in Catalysis (3 papers) and Drug Solubulity and Delivery Systems (3 papers). The work is most often cited by research in Pharmaceutical Science (68 citations), Biomaterials (70 citations), Biomedical Engineering (187 citations), Molecular Medicine (17 citations) and Polymers and Plastics (43 citations). Lingjun Zeng has collaborated with scholars based in China. Frequent co-authors include Guanghui Gao, Bo Liu, Zhenzhen Chen, Chun Tao, Zhihong Liu, Zhihong Liu, Minxin Zhang, Xiaomu Hu, Song Hong-tao and Lijie Duan. Their work appears in journals such as International Journal of Pharmaceutics, ACS Applied Materials & Interfaces, Biomedicine & Pharmacotherapy, Journal of Pharmaceutical Sciences and Drug Delivery and Translational Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.